SCHEMBL13065738

SCHEMBL13065738

O=C(O)c1ccc(-c2c(C(=O)O)c3nc4ccccc4oc-3c(O)c2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GFER P55789 1/20 0.42
DHODH Q02127 4/20 0.41
LMNA P02545 3/20 0.40
PDE10A Q9Y233 1/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 3/20 0.40
MITF O75030 1/20 0.40
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 3/20 0.39
ALOX15 P16050 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065731 0.93 DHODH (0.47) HPGDCYP1A2CYP2C9CYP2C19DHODH
SCHEMBL13065735 0.90 LMNA (0.48) HPGDDHODHLMNAPDE10AMEN1
SCHEMBL13065732 0.90 MAPK14 (0.45) HPGDDHODHLMNAPDE10AMEN1
SCHEMBL13065729 0.87 KDM4E (0.51) HPGDCYP1A2DHODHLMNAMEN1
SCHEMBL16784744 0.87 PDE10A (0.40) HPGDCYP1A2CYP2C9CYP2C19GFER
SCHEMBL13065740 0.87 LMNA (0.39) HPGDCYP1A2CYP2C9CYP2C19GFER
SCHEMBL13065737 0.87 DHODH (0.39) HPGDDHODHLMNAPDE10AMEN1
SCHEMBL13065736 0.85 BCL9 (0.44) HPGDCYP1A2CYP2C9CYP2C19GFER
SCHEMBL13065611 0.82 GPR119 (0.39) HPGDDHODHMEN1KMT2AMAPT
SCHEMBL13065733 0.80 KDM4E (0.53) HPGDCYP2C9CYP2C19LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 HPGD 3218/4885CYP1A2 4778/4885CYP2C9 4629/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 HPGD 3218/4885CYP1A2 4778/4885CYP2C9 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.